Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Compérat

Showing results (11-20 of 242) with videos related to

Pageof 25
Sort By:
European Urology|April 11, 2020
What Does COVID-19 Mean for the Pathology-Urology Interaction?Eva Compérat
European Urology|May 15, 2026
Re: Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC TrialsEva Compérat
Annales De Pathologie|October 22, 2008
[Case 7. Perspectives in 2007 for bladder pathology. High-grade micropapillary urothelial carcinoma]Eva Compérat
Annales De Pathologie|February 27, 2025
[Case #7. Cytology of high-grade urothelial carcinoma]Eva Compérat
Current Opinion in Urology|January 8, 2026
Biomarkers and testing in pathologyEva Compérat
Archivos Espanoles De Urologia|March 12, 2019
New markers in prostate cancer: InmunohistochemicalEva Compérat
World Journal of Urology|October 13, 2021
Latest Developments and Current Problems in Bladder CancerEva Compérat
Annales De Pathologie|May 31, 2017
[Prostate cancer histoseminar: Update of the 2016 WHO classification - case n<sup>o</sup>1: bilateral prostatic adenocarcinoma, Gleason score 8 (4+4)]Eva Compérat
Histopathology|June 30, 2016
Immunochemical and molecular assessment of urothelial neoplasms and aspects of the 2016 World Health Organization classificationEva Compérat, Justine Varinot
Annales De Pathologie|April 6, 2021
[Lesions of the penis, the anatomy, epidemiology and carcinogenesis]Eva Compérat, Philippe Moguelet
Pageof 25

Showing results (11-20 of 242) with videos related to

Sort By:
Pageof 25
European Urology|April 11, 2020
What Does COVID-19 Mean for the Pathology-Urology Interaction?Eva Compérat
European Urology|May 15, 2026
Re: Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC TrialsEva Compérat
Annales De Pathologie|October 22, 2008
[Case 7. Perspectives in 2007 for bladder pathology. High-grade micropapillary urothelial carcinoma]Eva Compérat
Annales De Pathologie|February 27, 2025
[Case #7. Cytology of high-grade urothelial carcinoma]Eva Compérat
Current Opinion in Urology|January 8, 2026
Biomarkers and testing in pathologyEva Compérat
Archivos Espanoles De Urologia|March 12, 2019
New markers in prostate cancer: InmunohistochemicalEva Compérat
World Journal of Urology|October 13, 2021
Latest Developments and Current Problems in Bladder CancerEva Compérat
Annales De Pathologie|May 31, 2017
[Prostate cancer histoseminar: Update of the 2016 WHO classification - case n<sup>o</sup>1: bilateral prostatic adenocarcinoma, Gleason score 8 (4+4)]Eva Compérat
Histopathology|June 30, 2016
Immunochemical and molecular assessment of urothelial neoplasms and aspects of the 2016 World Health Organization classificationEva Compérat, Justine Varinot
Annales De Pathologie|April 6, 2021
[Lesions of the penis, the anatomy, epidemiology and carcinogenesis]Eva Compérat, Philippe Moguelet
Pageof 25